Medicare froze new enrollment for certain medical-supply companies for six months

Two paramedics prepare a stretcher inside an ambulance, ready for an emergency response.

Medicare has temporarily closed the enrollment door to certain categories of new medical-equipment suppliers nationwide. The six-month moratorium began February 27 and remains active as of August 2, giving CMS time to block new high-risk billing identities while existing enrolled suppliers continue operating under enhanced scrutiny.

The freeze targets new enrollment, not all equipment coverage

CMS’ active-moratoria page identifies specified high-risk durable medical equipment, prosthetics, orthotics and supplies businesses covered by the nationwide action. The policy prevents new providers in those categories from enrolling during the moratorium; it does not cancel Medicare’s durable-equipment benefit or automatically remove every current supplier.

Existing suppliers may keep billing if they remain eligible and compliant, while applications affected by the moratorium are denied subject to the governing procedures. Beneficiaries therefore should not assume a needed wheelchair, oxygen supply or other covered item has become unavailable. The practical task is locating a currently enrolled supplier that can furnish it under Medicare rules.


Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.

Federal law permits a six-month fraud-control pause

The Federal Register notice documents the February 27 effective date and legal scope. Provider-enrollment moratoria are temporary tools used when CMS identifies heightened fraud, waste or abuse risk. They can be extended in six-month increments if the agency makes the required determination.

A moratorium differs from a permanent ban and from a payment suspension against one company. It operates prospectively across a defined provider type or area. That makes the current status important: a six-month action that started in late February still controls in early August, but its future after the initial period depends on an official extension or termination notice.

Medical equipment has an identity-fraud problem

Equipment claims can be generated remotely using beneficiary identifiers, clinician information and a supplier billing number. Fraudsters may market braces or other products as free, secure an order of questionable necessity and bill Medicare at scale. A new corporate entity can replace one that attracts scrutiny unless enrollment controls examine owners and relationships.

The Center for Program Integrity combines enrollment screening with claims analytics and law-enforcement referrals. A temporary freeze gives those systems fewer new high-risk applicants to process while CMS addresses existing vulnerabilities. It is a program-level safeguard rather than an accusation against every business in the affected industry.

Assignment determines the beneficiary’s exposure

Medicare’s supplier directory can help locate enrolled businesses and identify those that accept assignment. When assignment applies, the supplier agrees to the Medicare-approved amount and the beneficiary generally owes the deductible and coinsurance rather than an unrestricted retail price.

A supplier that claims enrollment is “pending” should not pressure a patient to pay thousands of dollars upfront on the promise of later reimbursement. Written confirmation of the order, coverage rules, rental-versus-purchase terms and expected share can prevent a surprise balance. Plan rules may add network requirements for Medicare Advantage members.

The moratorium leaves a clear verification habit

Because enrollment status can change, a beneficiary should check the supplier at the time of each major order rather than relying on an old invoice. Unsolicited calls requesting a Medicare number should be declined, especially when the caller already knows a diagnosis and insists that a product is free.

The six-month freeze is current on August 2, but it is not permanent by default. CMS’ next official action will determine whether it ends or continues. Until then, the money-protection lesson is precise: coverage remains, selected new high-risk suppliers cannot enroll, and patients should use a verified existing supplier before accepting equipment or a bill.

New ownership can trigger a hidden enrollment problem

A storefront may look unchanged while its legal owner, tax identification number or Medicare enrollment has changed. During a moratorium, a sale or reorganization can require review that affects whether the successor may bill. Patients should pay attention to notices announcing a new company name and compare the supplier listed on a claim with the business that delivered the item.

Clinicians also need to know which suppliers remain usable. Sending an order to a business that cannot enroll can delay discharge or leave a patient paying cash. Hospitals and medical offices can maintain current referral lists, but beneficiaries should still confirm participation because directories and ownership transactions do not always update simultaneously.

A moratorium’s anti-fraud value depends on enforcement against evasion. Applicants may try to buy existing billing numbers or conceal common ownership instead of filing openly. CMS screening of changes in ownership, addresses and managing employees is therefore the companion to the public six-month freeze.

Beneficiaries should be cautious when a supplier says the moratorium requires a special enrollment fee from the patient. Enrollment is a relationship between the business and CMS, and a consumer cannot bypass the freeze by paying privately for paperwork. A legitimate cash purchase may still be possible, but it should be evaluated as an uncovered expense with a written price—not as a secret path to future Medicare reimbursement.

The initial period also gives policymakers evidence about access. If certain regions lose practical supply while enrollment is closed, CMS can compare complaints and delivery times with fraud-control gains. That balance should be decided through official data and notices, not by a marketer telling a patient that the government has banned all new equipment.

This article was researched and drafted with AI assistance and reviewed against the linked primary sources.

More Financial Reading